Back to Amova Asset Management Americas, Inc. Amova Asset Management Americas, Inc.

ARCTARCT
Showing 8 of 29 quarters

Position history for Amova Asset Management Americas, Inc.Amova Asset Management Americas, Inc.'s holdings in ARCTURUS THERAPEUTICS HLDGS

Amova Asset Management Americas, Inc. holds 2M shares of ARCT (ARCTURUS THERAPEUTICS HLDGS), worth $13.1M as of 2026-Q2. The position was decreased (-14.3% shares). ARCT represents 0.2% of Amova Asset Management Americas, Inc.'s portfolio.

Current Value

$13.1M

Current Shares

2M

Total Value Change

-$40.6M

Total Shares Change

-354,836

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2M
-14.3%
$13.1M0.2%$6.72
0
2026-Q1
Increased
2.3M
+12.9%
$17.6M0.2%$7.91
38
2025-Q4
Increased
2M
+4.0%
$12.4M0.1%$6.19
35
2025-Q3
Increased
1.9M
+6.4%
$35.9M0.3%$18.78
37
2025-Q2
Decreased
1.8M
-5.0%
$23.8M0.2%$13.33
0
2025-Q1
Decreased
1.9M
-6.7%
$20.4M0.3%$11.58
0
2024-Q4
Decreased
2.1M
-10.8%
$34.9M0.4%$16.58
0
2024-Q3
Increased
2.3M
+48.1%
$53.7M0.6%$22.03
57

Other major holders of ARCT: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used